GALERA THERAPEUTICS INC (GRTX) SEC filings
GRTX SEC filings moved a median of 0.00% by the close. GRTX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the GRTX overview →
55 measured GRTX SEC filing events.
Where these GRTX SEC filings landedvs 51 measured GRTX SEC filing reactions
| Middle 50% of GRTX SEC filing reactions | -6.73% to +4.15% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 51 |
Point-in-time · zero look-ahead
Half of the 51 GRTX SEC filing events with a measured close landed between -6.73% and +4.15%; 39% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form EFFECT Galera Therapeutics, | SEC filing · Form EFFECT | — | — | |
| Form 8-K Galera Therapeutics, For: Jul 12 | SEC filing · Form 8-K | — | — | |
| Form DEFA14C Galera Therapeutics, | SEC filing · Form DEFA14C | — | — | |
| Form 8-K Galera Therapeutics, For: Jul 07 | SEC filing · Form 8-K | +0.00% | +1.02% | |
| Form DEFA14C Galera Therapeutics, | SEC filing · Form DEFA14C | +0.00% | +1.02% | |
| Form DEFM14C Galera Therapeutics, | SEC filing · Form DEFM14C | +0.00% | +0.00% | |
| Form 8-K Galera Therapeutics, For: May 15 | SEC filing · Form 8-K | +0.00% | -8.10% | |
| Form 8-K Galera Therapeutics, For: May 11 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 10-Q Galera Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +0.00% | |
| Form 8-K Galera Therapeutics, For: May 08 | SEC filing · Form 8-K | +11.11% | +12.07% | |
| Form ARS Galera Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.00% | +7.18% | |
| Form DEF 14A Galera Therapeutics, For: May 08 | SEC filing · Form DEF | +0.00% | +7.18% | |
| Form 8-K Galera Therapeutics, For: Apr 14 | SEC filing · Form 8-K | +14.87% | +6.62% | |
| Form PRE 14A Galera Therapeutics, For: May 08 | SEC filing · Form PRE | +0.00% | +2.19% | |
| Form 8-K Galera Therapeutics, For: Apr 07 | SEC filing · Form 8-K | +0.00% | -1.19% | |
| Form 8-K Galera Therapeutics, For: Apr 03 | SEC filing · Form 8-K | +0.00% | -2.50% | |
| Form 10-K Galera Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -2.39% | +7.38% | |
| Form 8-K Galera Therapeutics, For: Feb 12 | SEC filing · Form 8-K | +0.00% | +16.74% | |
| Form 8-K Galera Therapeutics, For: Feb 06 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 10-Q Galera Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| Form 8-K Galera Therapeutics, For: Oct 21 | SEC filing · Form 8-K | +0.00% | +17.39% | |
| Form 8-K Galera Therapeutics, For: Oct 21 | SEC filing · Form 8-K | +47.22% | +27.78% | |
| Form 8-K Galera Therapeutics, For: Aug 27 | SEC filing · Form 8-K | +0.00% | -5.58% | |
| Form 10-Q Galera Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -7.28% | |
| Form 10-Q Galera Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -5.35% | -1.24% | |
| Form 8-K Galera Therapeutics, For: Mar 31 | SEC filing · Form 8-K | +0.00% | +3.27% | |
| Form 10-K Galera Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -0.92% | |
| Form 8-K/A Galera Therapeutics, For: Dec 30 | SEC filing · Form 8-K | +0.00% | +3.02% | |
| Form 8-K Galera Therapeutics, For: Feb 24 | SEC filing · Form 8-K | +0.00% | +3.66% | |
| Form DEF 14A Galera Therapeutics, For: Feb 24 | SEC filing · Form DEF | +6.67% | +6.67% | |
| Form D Galera Therapeutics, | SEC filing · Form D | +0.00% | +1.70% | |
| Form D Galera Therapeutics, | SEC filing · Form D | — | +0.00% | |
| Form 8-K Galera Therapeutics, For: Dec 30 | SEC filing · Form 8-K | +3.60% | +11.44% | |
| Form 8-K Galera Therapeutics, For: Dec 20 | SEC filing · Form 8-K | +6.76% | +10.32% | |
| Form 10-Q Galera Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -33.12% | -4.46% | |
| Form NT 10-Q Galera Therapeutics, For: Sep 30 | SEC filing · Form NT | +3.75% | +0.00% | |
| Form 8-K Galera Therapeutics, For: Oct 17 | SEC filing · Form 8-K | -1.66% | -21.85% | |
| Form 8-K Galera Therapeutics, For: Aug 31 | SEC filing · Form 8-K | +0.16% | +12.00% | |
| Form DEF 14A Galera Therapeutics, For: Oct 17 | SEC filing · Form DEF | +0.00% | -2.95% | |
| Form PRE 14A Galera Therapeutics, For: Oct 17 | SEC filing · Form PRE | +1.44% | -2.82% | |
| Form 10-Q Galera Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +7.82% | -11.91% | |
| Form 8-K Galera Therapeutics, For: Aug 14 | SEC filing · Form 8-K | +7.82% | -11.91% | |
| Form 8-K Galera Therapeutics, For: Aug 08 | SEC filing · Form 8-K | -27.78% | -25.36% | |
| Form 8-K Galera Therapeutics, For: Jun 04 | SEC filing · Form 8-K | -1.27% | -0.91% | |
| Form 8-K Galera Therapeutics, For: May 31 | SEC filing · Form 8-K | +4.31% | -8.00% | |
| Form 10-Q Galera Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | — | -0.79% | |
| Form 8-K Galera Therapeutics, For: May 13 | SEC filing · Form 8-K | — | -0.79% | |
| Form 8-A12B Galera Therapeutics, | SEC filing · Form 8-A12B | -4.63% | -8.95% | |
| Form 8-K Galera Therapeutics, For: May 02 | SEC filing · Form 8-K | -4.63% | -8.95% | |
| Form 10-K Galera Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -0.69% | -12.50% | |
| Form 8-K Galera Therapeutics, For: Mar 28 | SEC filing · Form 8-K | -0.69% | -12.50% | |
| Form 8-K Galera Therapeutics, For: Mar 21 | SEC filing · Form 8-K | -5.56% | -14.68% | |
| Form 10-Q Galera Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -3.73% | -6.73% | |
| Form 8-K Galera Therapeutics, For: Nov 14 | SEC filing · Form 8-K | -3.73% | -6.73% | |
| Form 8-K Galera Therapeutics, For: Oct 31 | SEC filing · Form 8-K | +13.04% | +4.63% |
Keep exploring
More GRTX: earnings → · analyst actions → · GRTX overview →